SNOA
Sonoma Pharmaceuticals Inc
NASDAQ · Pharmaceuticals
$3.03
-0.03 (-0.98%)
Open$3.00
Previous Close$3.06
Day High$3.16
Day Low$2.91
52W High$14.48
52W Low$5.75
Volume—
Avg Volume495.4K
Market Cap5.15M
P/E Ratio13.15
EPS$0.75
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+326.7% upside
Current
$3.03
$3.03
Target
$12.93
$12.93
$7.21
$12.93 avg
$14.12
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 1.77M | 1.82M | 1.63M |
| Net Income | 442.4K | 463.1K | 348.9K |
| Profit Margin | 24.9% | 25.4% | 21.5% |
| EBITDA | 588.1K | 609.2K | 511.6K |
| Free Cash Flow | 272.5K | 381.4K | 338.4K |
| Rev Growth | +8.7% | -7.1% | +16.1% |
| Debt/Equity | 0.32 | 0.30 | 0.27 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |